1 nemia (T1T) and to enter clinical trials for alkaptonuria.

2 hich are linked to the human genetic disease alkaptonuria.

3 h the potential, but incorrect, diagnosis of alkaptonuria.

4  a study to delineate the natural history of alkaptonuria.

5 taneous hyperpigmentation resembling that of alkaptonuria.

6                                              Alkaptonuria, a rare autosomal-recessive disorder caused

7                We evaluated 58 patients with alkaptonuria (age range, 4 to 80 years), using clinical,

8 le for the other three conditions (albinism, alkaptonuria, and cystinuria) have been identified, but

9            Hereditary tyrosinemia type I and alkaptonuria are disorders of tyrosine catabolism caused

10  joints, were diagnosed clinically as having alkaptonuria, but the diagnosis was withdrawn based on n

11                                        Using alkaptonuria cartilage specimens with a wide spectrum of

12                                              Alkaptonuria, caused by mutations in the HGO gene and a

13                                              Alkaptonuria is a genetic disorder of tyrosine metabolis

14 ease that affects the liver and kidneys, but alkaptonuria is a more benign adult disorder in comparis

15                                   Ochronosis/Alkaptonuria is a tyrosine metabolism disorder where acc

16  severities of ochronosis were obtained from alkaptonuria patients undergoing surgery and compared to

17  The reported data on the natural history of alkaptonuria provide a basis for the evaluation of long-

18                                           In alkaptonuria samples with the least advanced ochronosis,

19 t the tyrosinemic locus but heterozygous for alkaptonuria spontaneously developed clonal nodules of f

20                             The diagnosis of alkaptonuria was confirmed or ruled out by measurement o

21 -eight patients with a possible diagnosis of alkaptonuria were examined at the National Institutes of